A study of individuals with social anxiety disorder in Finland found that the activation of the left inferior frontal gyrus ...

With a late-stage miss reported for its prospective social anxiety disorder (SAD) treatment fasedienol, Vistagen’s chances at ...

Fasedienol is a first-in-class pherine nasal spray that is designed to modulate the olfactory-limbic amygdala fear and anxiety neurocircuits.

Vistagen shares plunge after its Phase 3 fasedienol trial for social anxiety failed to meet the primary endpoint, despite favorable safety data.

Vistagen (VTGN) on Wednesday announced that a Phase 3 trial for fasedienol, an experimental therapy for social anxiety ...

A lot of us get nervous in social situations, such as going on a first date, dinner with friends or speaking in front of a group of people. But at what point do nerves turn into full-blown social ...

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Stephen Neely receives funding from the Florida Center for Cybersecurity for this study Kaila Witkowski receives funding from the Florida Center for Cybersecurity for this study. Over 40 million ...